NuriBio Co., Ltd.
Research
Biotechnology
Research
Founded in 2014
+82 31-389-9978
Anyang
Overview
Email Format
Org Chart
Technology
News & Signals
NuriBio Co., Ltd. information
NuriBio specializes in research and development of gene analysis, primarily focusing in detection of mutations caused by diseases such as cancer. Our proprietary PROMER™ technology which has increased sensitivity and specificity, powers our Ctrl-X® mutation detection kits for diagnosis, early screening, and prognosis of cancer patients.
Highlights
4
Employee contacts
3
Employee email addresses
Unlock for free
Employee phone numbers
9
Technologies
0
News and Milestones
0
Job Postings
Financials
Industries
Research
Biotechnology
Keywords
Gene analysis
Reagents
Qpcr
Mutation detection
Mirna detection
Biotechnology research
NuriBio Co., Ltd. Frequently Asked Questions
Who is the CEO of NuriBio Co., Ltd.?
The CEO of NuriBio Co., Ltd. is Young-Hyean Nam.
Where is NuriBio Co., Ltd.'s headquarters?
NuriBio Co., Ltd.'s headquarters is located in Anyang, South Korea.
How many employees does NuriBio Co., Ltd. have?
There are 8 employees at NuriBio Co., Ltd..
How many funding rounds does NuriBio Co., Ltd. have?
NuriBio Co., Ltd. has been through 0 rounds of funding.
Employees
Looking for a particular NuriBio Co., Ltd. Employee?
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
